 |
市场调查报告书
商品编码
1672801
全球骨髓移植市场按类型、治疗类型、最终用户和地区划分Bone Marrow Transplant Market, By Type, By Treatment Type, By End User, By Geography |
||||||
价格
简介目录
2025 年全球骨髓移植市场规模预估为 112 亿美元，预计到 2032 年将达到 152.6 亿美元，2025 年至 2032 年的复合年增长率为 4.5%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 112亿美元 |
| 效能资料 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年复合年增长率： | 4.50％ | 2032 年价值预测 | 152.6亿美元 |
数字。 2025 年骨髓移植市场占有率（%），依地区划分
骨髓移植是将健康的骨髓干细胞注入患者体内以取代受损或不健康的骨髓的过程。骨髓移植常用于治疗多种血癌，包括白血病、淋巴瘤和其他血液疾病。干细胞可以从患者（自体移植）或捐赠者（同种异体移植）获得。同种异体移植比自体移植的成功率更高，因为捐赠的干细胞可以产生健康的新细胞。然而，由于免疫排斥，併发症的风险也更高。移植程序的进步和与捐赠者匹配的改善导致了对骨髓移植的巨大需求。
市场动态：
全球骨髓移植市场的成长是由全球血癌和其他血液疾病发生率的上升所推动的。根据世界卫生组织发布的资料，2018年全球通报的癌症新病例约1,810万，癌症死亡病例约960万。此外，人们对移植作为有效替代疗法的认识不断提高，对免疫抑制剂研发的投资不断增加，正在推动市场的发展。然而，移植手术的高成本、兼容捐赠者的有限性以及移植后移植排斥的风险可能会阻碍市场的成长。此外，采用周边血干细胞作为骨髓替代疗法也阻碍了市场的成长。干细胞疗法的发展很可能在不久的将来为市场进入者提供丰厚的机会。
本研究的主要特点
- 本报告对全球骨髓移植市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和复合年增长率。
- 它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
- 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
- 全球骨髓移植市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球骨髓移植市场报告涵盖了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员将透过用于分析全球骨髓移植市场的各种策略矩阵更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管情景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第 4 章。全球骨髓移植市场：COVID-19 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 市场影响
第 5 章。全球骨髓移植市场按类型划分（2020-2032 年）
- 自体移植
- 同种异体移植
- 其他的
6. 全球骨髓移植市场依治疗类型划分（2020-2032 年）
- 白血病
- 淋巴瘤
- 骨髓瘤
- 骨髓发育不良症候群
- 骨髓增生性疾病
- 再生障碍性贫血
- 固态肿瘤
- 镰状细胞性贫血
- 地中海型贫血
- 其他的
7. 全球骨髓移植市场以最终用户划分（2020-2032 年）
- 医院
- 多专科诊所
- 门诊手术中心
8. 全球骨髓移植市场按地区划分（2020-2032 年）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第九章 竞争格局
- 公司简介
- Merck Millipore Corporation
- Sanofi-Aventis LLC.
- AllCells LLC.
- STEMCELL Technologies
- ATCC Inc.
- Hemacare Corporation
- Cellular Dynamics International
- ReachBio LLC.
- Conversant Bio ABM Inc.
- PromoCell GmbH
- Cruline Human biospecimen PRO
- Lifeline Cell Technology
- Mesoblast Ltd.
- Actinium Pharmaceuticals, Inc
- Bluebird Bio, Inc
- Gilead Sciences, Inc
- Novartis AG
第 10 章分析师建议
- 命运之轮
- 分析师观点
- Coherent Opportunity Map（COM）
第 11 章 参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI232
Global Bone Marrow Transplant Market is estimated to be valued at USD 11.20 Bn in 2025 and is expected to reach USD 15.26 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 11.20 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.50% | 2032 Value Projection: | USD 15.26 Bn |
Figure. Bone Marrow Transplant Market Share (%), By Region 2025
Bone marrow transplant is a procedure that infuses healthy bone marrow stem cells to replace the damaged or unhealthy bone marrow of a patient. It is commonly used for treating various blood cancers like leukemia, lymphoma and other blood disorders. The stem cells can either be obtained from the patient (autologous transplant) or from a donor (allogeneic transplant). Allogeneic transplants have shown more success rates as compared to autologous as the donated stem cells can produce healthy new cells. However, it also carries higher risks of complications due to immune rejection. With advancements in transplant procedures and better donor matching, there has been huge demand for bone marrow transplants.
Market Dynamics:
Global bone marrow transplant market growth is driven by rising prevalence of blood cancers and other hematological disorders worldwide. According to the data published by WHO, around 18.1 million new cancer cases and 9.6 million cancer deaths were reported in 2018 globally. Furthermore, growing awareness about transplantation as an effective treatment alternative and increasing investment in research & development of immunosuppressant drugs are driving the market growth. However, high costs associated with transplant procedures, limited availability of matched donors, and risks of graft rejection post-transplant can hamper the market growth. Adoption of peripheral blood stem cells as an alternative to bone marrow can also hamper the market growth. The development of stem cell therapies can offer lucrative opportunities for market players in the near future.
Key Features of the Study:
- This report provides in-depth analysis of the global bone marrow transplant market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global bone marrow transplant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AllCells, ReachBio LLC, Conversant Bio, Cellular Dynamics International, and Takeda Pharmaceuticals
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global bone marrow transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone marrow transplant market
Detailed Segmentation-
- By Type
- Autologous Transplant
- Allogenic Transplant
- Others
- By Treatment Type
- Leukemia
- Lymphoma
- Myeloma
- Myelodysplastic Syndrome
- Myeloproliferative Disorders
- Aplastic Anemia
- Solid Tumors
- Sickle cell Anemia
- Thalassemia
- Others
- By End User
- Hospitals
- Multi-specialty Clinics
- Ambulatory Surgical Centers
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Merck Millipore Corporation
- Sanofi-Aventis LLC.
- AllCells LLC.
- STEMCELL Technologies
- ATCC Inc.
- Hemacare Corporation
- Cellular Dynamics International
- ReachBio LLC.
- Conversant Bio ABM Inc.
- PromoCell GmbH
- Cruline Human biospecimen PRO
- Lifeline Cell Technology
- Mesoblast Ltd.
- Actinium Pharmaceuticals, Inc
- Bluebird Bio, Inc
- Gilead Sciences, Inc
- Novartis AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Treatment Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Bone Marrow Transplant Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Bone Marrow Transplant Market, By Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Autologous Transplant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Allogenic Transplant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Bone Marrow Transplant Market, By Treatment Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Leukemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Myeloma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Myelodysplastic Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Myeloproliferative Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Aplastic Anemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Solid Tumors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sickle cell Anemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Thalassemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Bone Marrow Transplant Market, By End User, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Multi-specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Bone Marrow Transplant Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Merck Millipore Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi-Aventis LLC.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AllCells LLC.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- STEMCELL Technologies
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ATCC Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hemacare Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cellular Dynamics International
- ReachBio LLC.
- Conversant Bio ABM Inc.
- PromoCell GmbH
- Cruline Human biospecimen PRO
- Lifeline Cell Technology
- Mesoblast Ltd.
- Actinium Pharmaceuticals, Inc
- Bluebird Bio, Inc
- Gilead Sciences, Inc
- Novartis AG
- Merck Millipore Corporation
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
"
